Franklin Street Advisors’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-15
| Closed | -$31K | – | 166 |
|
|
2018
Q2 | $31K | Buy |
15
+1
| +7% | +$2.07K | ﹤0.01% | 159 |
|
|
2018
Q1 | $40K | Hold |
14
| – | – | 0.01% | 163 |
|
|
2017
Q4 | $64K | Buy |
14
+8
| +133% | +$36.6K | 0.01% | 163 |
|
|
2017
Q3 | $49K | Hold |
6
| – | – | 0.01% | 156 |
|
|
2017
Q2 | $29K | Sell |
6
-8
| -57% | -$38.7K | 0.01% | 149 |
|
|
2017
Q1 | $79K | Hold |
14
| – | – | 0.01% | 153 |
|
|
2016
Q4 | $96K | Hold |
14
| – | – | 0.02% | 165 |
|
|
2016
Q3 | $217K | Hold |
14
| – | – | 0.04% | 166 |
|
|
2016
Q2 | $227K | Hold |
14
| – | – | 0.04% | 175 |
|
|
2016
Q1 | $297K | Buy |
14
+6
| +75% | +$127K | 0.06% | 177 |
|
|
2015
Q4 | $169K | Hold |
8
| – | – | 0.03% | 209 |
|
|
2015
Q3 | $168K | Hold |
8
| – | – | 0.03% | 209 |
|
|
2015
Q2 | $211K | Buy |
+8
| New | +$211K | 0.04% | 205 |
|